SEC Filings TLDR
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-10-03RKTSCHEDULE 13D/AAmendment No. 4 to Schedule 13D for Rocket Companies, Inc.MEDIUM
This Amendment No. 4 to Schedule 13D for Rocket Companies, Inc. provides updated information regarding the beneficial ownership of the company's Class A Common Stock by ValueAct Master Fund and related entities. As of October 1, 2025, ValueAct Master Fund acquired beneficial ownership of 16,113,625 shares of Common Sto...
2025-10-03MDWDSCHEDULE 13D/AAmendment No. 6 to Schedule 13D for MediWound Ltd.MEDIUM
This Amendment No. 6 to Schedule 13D is filed by Access Industries Holdings LLC, Access Industries, LLC, Access Industries Management, LLC, Clal Industries Ltd., Clal Biotechnology Industries Ltd., Clal Life Sciences L.P., and Len Blavatnik (collectively, the 'Reporting Persons') in respect of MediWound Ltd. The amendm...
2025-10-03FORASCHEDULE 13D/AAmendment No. 1 to Schedule 13D for Forian Inc.MEDIUM
This Amendment No. 1 to Schedule 13D, filed by 2025 Acquisition Corporation and other reporting persons, updates the ownership and transaction details regarding the common stock of Forian Inc. The amendment includes a confidentiality agreement entered into on September 29, 2025, between Forian Inc. and 2025 Acquisition...
2025-10-03DELLSCHEDULE 13D/AAmendment No. 12 to Schedule 13D for Dell Technologies Inc. by Silver Lake GroupMEDIUM
This filing represents Amendment No. 12 to the Schedule 13D initially filed on February 19, 2019, by Silver Lake Group, L.L.C. and its affiliates (the Reporting Persons) regarding their holdings in Dell Technologies Inc. The amendment updates the beneficial ownership of Class C Common Stock, par value $0.01 per share, ...
2025-10-03ALZNSCHEDULE 13D/AAmendment to Schedule 13D for Alzamend Neuro, Inc.MEDIUM
This filing is an amendment to Schedule 13D for Alzamend Neuro, Inc., disclosing changes in beneficial ownership of the company's common stock. The amendment includes detailed information on the number of shares owned by various entities and individuals, including Milton C. Ault, III, William B. Horne, Henry C.W. Nisse...
2025-10-03ARTLSCHEDULE 13D/AAmendment to Schedule 13D for Artelo Biosciences, Inc.MEDIUM
This filing is an amendment to the Schedule 13D for Artelo Biosciences, Inc., submitted by Daniel S. Farb. The amendment updates the ownership details and transactions related to the company's common stock. As of the date of this filing, Farb directly owns 153,003 shares, constituting approximately 7.7% of the outstand...
2025-10-02WHLRSCHEDULE 13D/ADisposal of Shares by Diveroli Investment Group LLC and Kingbird Ventures LLCMEDIUM
This Amendment to Schedule 13D reports that Diveroli Investment Group LLC and Kingbird Ventures LLC have disposed of all shares of common stock previously reported as beneficially owned in Wheeler Real Estate Investment Trust, Inc. The Reporting Persons no longer beneficially own any shares of the Issuer. The transacti...
2025-10-02YOSHSCHEDULE 13D/AJames Chae's Schedule 13D/A Filing for Vestand Inc.MEDIUM
James Chae, the CEO of Eastvale K-BBQ, filed an amended Schedule 13D/A for Vestand Inc., disclosing his ownership of 2,973,400 shares of Class A common stock, representing approximately 20.5% of the outstanding shares. The filing details the acquisition of a warrant to purchase 1,120,000 shares of Class A common stock ...
2025-10-02VEROSCHEDULE 13D/AAmendment No. 10 to Schedule 13D for Venus Concept Inc.MEDIUM
This Amendment No. 10 to Schedule 13D, filed by Madryn Asset Management, LP and related entities, updates the ownership and transaction details of Venus Concept Inc.'s common stock. The amendment is primarily related to the execution of the September 2025 Exchange Agreement, where the Funds exchanged $15,000,000 of sen...
2025-10-02RGRSCHEDULE 13D/AAmendment No. 1 to Schedule 13D by Beretta Holding S.A. for Sturm Ruger & Co IncMEDIUM
Beretta Holding S.A. has filed Amendment No. 1 to its Schedule 13D for Sturm Ruger & Co Inc, disclosing its ownership of 1,454,900 shares, representing 9.002% of the company's outstanding common stock. The shares were acquired with working capital at an aggregate purchase price of approximately $54.8 million, including...
2025-10-02OPADSCHEDULE 13D/AAmendment No. 2 to Schedule 13D for Offerpad Solutions Inc.MEDIUM
This Amendment No. 2 to Schedule 13D, filed on October 2, 2025, updates the ownership details of Class A Common Stock of Offerpad Solutions Inc. The filing reports that LL Capital Partners I, L.P. and SIF V, LLC completed in-kind distributions of shares to their limited partners on September 30, 2025. Following these d...
2025-10-02OPADSCHEDULE 13D/AAmendment No. 2 to Schedule 13D for Offerpad Solutions Inc.MEDIUM
This Amendment No. 2 to Schedule 13D, filed by LL Capital Partners I, L.P. and other reporting persons, updates the ownership details of Class A Common Stock of Offerpad Solutions Inc. The amendment reflects an in-kind distribution of shares by LL Capital Partners I, L.P. and SIF V, LLC to their limited partners on Sep...
2025-10-02MSWSCHEDULE 13D/AAmendment No. 3 to Schedule 13D for Ming Shing Group Holdings LtdMEDIUM
This Amendment No. 3 to Schedule 13D, filed by Mr. Chi Ming Lam, updates the ownership details of Ming Shing Group Holdings Ltd's ordinary shares. As of October 1, 2025, Mr. Lam holds 10,473,500 ordinary shares, representing 80.7% of the issued and outstanding shares. The amendment details a series of transactions wher...
2025-10-02KALASCHEDULE 13D/AAmendment No. 2 to Schedule 13D for KALA BIO, Inc.MEDIUM
This Amendment No. 2 to Schedule 13D, filed by Baker Bros. Advisors LP and related entities, reports the sale of common stock of KALA BIO, Inc. that resulted in a more than 1 percent change in beneficial ownership. The amendment also details the conversion rights of Series E, F, G, and H Preferred Stock into Common Sto...
2025-10-02FORASCHEDULE 13D/AAmendment No. 2 to Schedule 13D for Forian Inc.MEDIUM
This Amendment No. 2 to Schedule 13D, filed on October 2, 2025, pertains to the common stock of Forian Inc. The filing is made by Max C. Wygod, Emily Bushnell, the Administrative Trust U/Wygod Family RV, the Wygod Family Rev LT U/T/A, and the Estate of Martin J. Wygod. The amendment updates the beneficial ownership of ...
2025-10-02FISISCHEDULE 13D/APL Capital Advisors and Black Maple Capital Report 8.9% Ownership in Financial Institutions, Inc.MEDIUM
PL Capital Advisors, LLC, Black Maple Capital Management LP, and related entities have filed an amended Schedule 13D reporting an aggregate 8.9% ownership in Financial Institutions, Inc. The filing indicates that the Reporting Persons acquired the Common Stock because they believed it was undervalued at the time of pur...
2025-10-02COCPSCHEDULE 13D/AAmendment to Schedule 13D for Cocrystal Pharma, Inc. by Phillip Frost, M.D. and Frost Gamma Investments TrustMEDIUM
This filing is an amendment to Schedule 13D for Cocrystal Pharma, Inc., submitted by Phillip Frost, M.D. and Frost Gamma Investments Trust. The amendment reports the acquisition of shares of common stock through the vesting of restricted stock units. Dr. Frost acquired 13,550 shares on August 21, 2025, and 1,693 shares...
2025-10-02CIFRWSCHEDULE 13D/AAmendment No. 17 to Schedule 13D for Cipher Mining Inc.MEDIUM
This filing, Amendment No. 17 to Schedule 13D, pertains to the common stock of Cipher Mining Inc. The amendment updates the beneficial ownership details of the reporting persons, including Bitfury Top HoldCo B.V., Bitfury Holding B.V., Bitfury Group Ltd, V3 Holding Ltd, and Valerijs Vavilovs. The filing discloses recen...
2025-10-02CDLRSCHEDULE 13D/AAmendment No. 2 to Schedule 13D for Cadeler A/S by BW Altor Pte. Ltd.MEDIUM
This Amendment No. 2 to Schedule 13D, filed by BW Altor Pte. Ltd. (BWA), updates the ownership details of Cadeler A/S shares. BWA now holds 78,495,522 ordinary shares, representing approximately 22.4% of the outstanding shares. The funds used for these acquisitions came from an equity injection by Mr. Sohmen-Pao using ...
2025-10-01ZVIASCHEDULE 13D/AAmendment No. 2 to Schedule 13D for Zevia PBCMEDIUM
This filing is Amendment No. 2 to the Schedule 13D originally filed on August 5, 2021, and previously amended on July 2, 2025, by CDP Investissements Inc. and Caisse de Depot et Placement du Quebec regarding their holdings in Zevia PBC. The amendment updates the citizenship of the officers and directors of the reportin...
2025-10-01OPSCHEDULE 13D/AAmendment No. 21 to Schedule 13D for OceanPal Inc.MEDIUM
This Amendment No. 21 to the Schedule 13D for OceanPal Inc. reports a decrease in the percentage ownership of Shares that the Reporting Persons, Ioannis Zafirakis and Abra Marinvest Inc., may be deemed to beneficially own. The decrease is due to changes in the conversion price of the Series C and Series D Preferred Sto...
2025-10-01OPSCHEDULE 13D/AAmendment No. 16 to Schedule 13D for OceanPal Inc.MEDIUM
This Amendment No. 16 to the Schedule 13D for OceanPal Inc. reports a decrease in the percentage ownership of Shares that Eleftherios Papatrifon, the Reporting Person, may be deemed to beneficially own through his ownership of the Issuer's Series C Preferred Stock and Series D Preferred Stock. The decrease is due to a ...
2025-10-01OPSCHEDULE 13D/AAmendment No. 41 to Schedule 13D for OceanPal Inc.MEDIUM
Amendment No. 41 to the Schedule 13D for OceanPal Inc. reports a decrease in the percentage ownership of Shares that the Reporting Persons may be deemed to beneficially own through their ownership of the Issuer's Series C Preferred Stock and Series D Preferred Stock. The amendment is filed by Semiramis Paliou, Tuscany ...
2025-10-01OPKSCHEDULE 13D/AAmendment No. 27 to Schedule 13D for OPKO Health, Inc.MEDIUM
Amendment No. 27 to Schedule 13D for OPKO Health, Inc. discloses changes in the beneficial ownership of the company's common stock by The Frost Group, LLC, Frost Gamma Investments Trust, Frost Nevada Investments Trust, and Phillip Frost, M.D. The amendment highlights that Gamma Trust directly owns 214,236,448 shares (2...
2025-10-01SMRSCHEDULE 13D/AAmendment No. 4 to Schedule 13D/A for NuScale Power CorpMEDIUM
This Amendment No. 4 to Schedule 13D/A, filed jointly by Fluor Corporation, Fluor Enterprises, Inc., and NuScale Holdings Corp., updates the ownership details of Class A Common Stock of NuScale Power Corporation. The amendment discloses that Fluor Enterprises exchanged 15,000,000 Class B common units for 15,000,000 sha...